首页 > 最新文献

Bacteriological Reviews最新文献

英文 中文
Cyclic adenosine 5'-monophosphate in Escherichia coli. 大肠杆菌中的环腺苷5'-单磷酸。
Pub Date : 1976-09-01 DOI: 10.1128/MMBR.40.3.527-551.1976
I. Pastan, ArD Sankar Adhya
INTRODUCTION ................ ROLE OF CYCLIC AMP IN REGULATION OF GENE EXPRESSION .......... A Positive Element in Gene Expression ...................................... CRP .......................... :........................................... Direct stimulation of gene expression ...................................... Possible Role As a Negative Element ......................................... Does Cyclic AMP Rave Other Actions in E. co .............................. OPERON ACTIVATION BY CYCLIC AMP .................................... Genetic analysis of the lac promoter ....................................... CONTROL OF CYCLIC AMP LEVELS ........................................ Adenylate Cyclase ........................................................... Cyclic AMP Phosphodiesterase ...................................... Cyclic AMP Release ......................................................... Rate of Cyclic AMP Synthesis ............................................... CYCLIC AMP RECEPTOR PROTEIN ........................................ Physical properties of CRP ................................................ Cyclic AMP binding .... Promoter-specific DNAbinding. Effects of cyclic AMP on CRP structure .................................... CYCLIC AMP AND BACTERIOPHAGE A ...................................... CYCLIC GMP ................................................................ CONCLUSION ................................................................ LITERATURE CITED ........................................................
介绍 ................环amp在基因表达调控中的作用..........基因表达的积极因素 ......................................c反应蛋白 ..........................:...........................................基因表达的直接刺激 ......................................可能作为一个负面元素 .........................................在e公司环腺苷酸狂欢其他操作吗 ..............................操纵子环腺苷酸活化 ....................................lac启动子的基因分析 .......................................环腺苷酸水平的控制 ........................................腺苷酸环化酶 ...........................................................环腺苷酸磷酸二酯酶 ......................................环腺苷酸释放 .........................................................环腺苷酸的合成 ...............................................环腺苷酸受体蛋白 ........................................c反应蛋白的物理性质 ................................................环AMP结合....Promoter-specific DNAbinding。环腺苷酸对CRP的影响结构 ....................................环腺苷酸和噬菌体 ......................................环磷鸟苷 ................................................................结论 ................................................................文献引用 ........................................................
{"title":"Cyclic adenosine 5'-monophosphate in Escherichia coli.","authors":"I. Pastan, ArD Sankar Adhya","doi":"10.1128/MMBR.40.3.527-551.1976","DOIUrl":"https://doi.org/10.1128/MMBR.40.3.527-551.1976","url":null,"abstract":"INTRODUCTION ................ ROLE OF CYCLIC AMP IN REGULATION OF GENE EXPRESSION .......... A Positive Element in Gene Expression ...................................... CRP .......................... :........................................... Direct stimulation of gene expression ...................................... Possible Role As a Negative Element ......................................... Does Cyclic AMP Rave Other Actions in E. co .............................. OPERON ACTIVATION BY CYCLIC AMP .................................... Genetic analysis of the lac promoter ....................................... CONTROL OF CYCLIC AMP LEVELS ........................................ Adenylate Cyclase ........................................................... Cyclic AMP Phosphodiesterase ...................................... Cyclic AMP Release ......................................................... Rate of Cyclic AMP Synthesis ............................................... CYCLIC AMP RECEPTOR PROTEIN ........................................ Physical properties of CRP ................................................ Cyclic AMP binding .... Promoter-specific DNAbinding. Effects of cyclic AMP on CRP structure .................................... CYCLIC AMP AND BACTERIOPHAGE A ...................................... CYCLIC GMP ................................................................ CONCLUSION ................................................................ LITERATURE CITED ........................................................","PeriodicalId":55406,"journal":{"name":"Bacteriological Reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1976-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63728627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 287
Bacteriocins of gram-positive bacteria. 革兰氏阳性细菌的细菌素。
Pub Date : 1976-09-01 DOI: 10.1128/br.40.3.722-756.1976
J R Tagg, A S Dajani, L W Wannamaker
In recent years, a group of antibacterial proteins produced by gram-positive bacteria have attracted great interest in their potential use as food preservatives and as antibacterial agents to combat certain infections due to gram-positive pathogenic bacteria. They are ribosomally synthesized peptides of 30 to less than 60 amino acids, with a narrow to wide antibacterial spectrum against gram-positive bacteria; the antibacterial property is heat stable, and a producer strain displays a degree of specific self-protection against its own antibacterial peptide. In many respects, these proteins are quite different from the colicins and other bacteriocins produced by gram-negative bacteria, yet customarily they also are grouped as bacteriocins. Although a large number of these bacteriocins (or bacteriocin-like inhibitory substances) have been reported, only a few have been studied in detail for their mode of action, amino acid sequence, genetic characteristics, and biosynthesis mechanisms. Nevertheless, in general, they appear to be translated as inactive prepeptides containing an N-terminal leader sequence and a C-terminal propeptide component. During posttranslational modifications, the leader peptide is removed. In addition, depending on the particular type, some amino acids in the propeptide components may undergo either dehydration and thioether ring formation to produce lanthionine and beta-methyl lanthionine (as in lantibiotics) or thio ester ring formation to form cystine (as in thiolbiotics). Some of these steps, as well as the translocation of the molecules through the cytoplasmic membrane and producer self-protection against the homologous bacteriocin, are mediated through specific proteins (enzymes). Limited genetic studies have shown that the structural gene for such a bacteriocin and the genes encoding proteins associated with immunity, translocation, and processing are present in a cluster in either a plasmid, the chromosome, or a transposon. Following posttranslational modification and depending on the pH, the molecules may either be released into the environment or remain bound to the cell wall. The antibacterial action against a sensitive cell of a gram-positive strain is produced principally by destabilization of membrane functions. Under certain conditions, gram-negative bacterial cells can also be sensitive to some of these molecules. By application of site-specific mutagenesis, bacteriocin variants which may differ in their antimicrobial spectrum and physicochemical characteristics can be produced. Research activity in this field has grown remarkably but sometimes with an undisciplined regard for conformity in the definition, naming, and categorization of these molecules and their genetic effectors. Some suggestions for improved standardization of nomenclature are offered.
{"title":"Bacteriocins of gram-positive bacteria.","authors":"J R Tagg, A S Dajani, L W Wannamaker","doi":"10.1128/br.40.3.722-756.1976","DOIUrl":"https://doi.org/10.1128/br.40.3.722-756.1976","url":null,"abstract":"In recent years, a group of antibacterial proteins produced by gram-positive bacteria have attracted great interest in their potential use as food preservatives and as antibacterial agents to combat certain infections due to gram-positive pathogenic bacteria. They are ribosomally synthesized peptides of 30 to less than 60 amino acids, with a narrow to wide antibacterial spectrum against gram-positive bacteria; the antibacterial property is heat stable, and a producer strain displays a degree of specific self-protection against its own antibacterial peptide. In many respects, these proteins are quite different from the colicins and other bacteriocins produced by gram-negative bacteria, yet customarily they also are grouped as bacteriocins. Although a large number of these bacteriocins (or bacteriocin-like inhibitory substances) have been reported, only a few have been studied in detail for their mode of action, amino acid sequence, genetic characteristics, and biosynthesis mechanisms. Nevertheless, in general, they appear to be translated as inactive prepeptides containing an N-terminal leader sequence and a C-terminal propeptide component. During posttranslational modifications, the leader peptide is removed. In addition, depending on the particular type, some amino acids in the propeptide components may undergo either dehydration and thioether ring formation to produce lanthionine and beta-methyl lanthionine (as in lantibiotics) or thio ester ring formation to form cystine (as in thiolbiotics). Some of these steps, as well as the translocation of the molecules through the cytoplasmic membrane and producer self-protection against the homologous bacteriocin, are mediated through specific proteins (enzymes). Limited genetic studies have shown that the structural gene for such a bacteriocin and the genes encoding proteins associated with immunity, translocation, and processing are present in a cluster in either a plasmid, the chromosome, or a transposon. Following posttranslational modification and depending on the pH, the molecules may either be released into the environment or remain bound to the cell wall. The antibacterial action against a sensitive cell of a gram-positive strain is produced principally by destabilization of membrane functions. Under certain conditions, gram-negative bacterial cells can also be sensitive to some of these molecules. By application of site-specific mutagenesis, bacteriocin variants which may differ in their antimicrobial spectrum and physicochemical characteristics can be produced. Research activity in this field has grown remarkably but sometimes with an undisciplined regard for conformity in the definition, naming, and categorization of these molecules and their genetic effectors. Some suggestions for improved standardization of nomenclature are offered.","PeriodicalId":55406,"journal":{"name":"Bacteriological Reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1976-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC413978/pdf/bactrev00053-0204.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11981131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 782
Cyclic adenosine 5'-monophosphate in Escherichia coli. 大肠杆菌中的环腺苷5'-单磷酸。
Pub Date : 1976-09-01 DOI: 10.1128/br.40.3.527-551.1976
I Pastan, S Adhya
INTRODUCTION ................ ROLE OF CYCLIC AMP IN REGULATION OF GENE EXPRESSION .......... A Positive Element in Gene Expression ...................................... CRP .......................... :........................................... Direct stimulation of gene expression ...................................... Possible Role As a Negative Element ......................................... Does Cyclic AMP Rave Other Actions in E. co .............................. OPERON ACTIVATION BY CYCLIC AMP .................................... Genetic analysis of the lac promoter ....................................... CONTROL OF CYCLIC AMP LEVELS ........................................ Adenylate Cyclase ........................................................... Cyclic AMP Phosphodiesterase ...................................... Cyclic AMP Release ......................................................... Rate of Cyclic AMP Synthesis ............................................... CYCLIC AMP RECEPTOR PROTEIN ........................................ Physical properties of CRP ................................................ Cyclic AMP binding .... Promoter-specific DNAbinding. Effects of cyclic AMP on CRP structure .................................... CYCLIC AMP AND BACTERIOPHAGE A ...................................... CYCLIC GMP ................................................................ CONCLUSION ................................................................ LITERATURE CITED ........................................................
{"title":"Cyclic adenosine 5'-monophosphate in Escherichia coli.","authors":"I Pastan, S Adhya","doi":"10.1128/br.40.3.527-551.1976","DOIUrl":"https://doi.org/10.1128/br.40.3.527-551.1976","url":null,"abstract":"INTRODUCTION ................ ROLE OF CYCLIC AMP IN REGULATION OF GENE EXPRESSION .......... A Positive Element in Gene Expression ...................................... CRP .......................... :........................................... Direct stimulation of gene expression ...................................... Possible Role As a Negative Element ......................................... Does Cyclic AMP Rave Other Actions in E. co .............................. OPERON ACTIVATION BY CYCLIC AMP .................................... Genetic analysis of the lac promoter ....................................... CONTROL OF CYCLIC AMP LEVELS ........................................ Adenylate Cyclase ........................................................... Cyclic AMP Phosphodiesterase ...................................... Cyclic AMP Release ......................................................... Rate of Cyclic AMP Synthesis ............................................... CYCLIC AMP RECEPTOR PROTEIN ........................................ Physical properties of CRP ................................................ Cyclic AMP binding .... Promoter-specific DNAbinding. Effects of cyclic AMP on CRP structure .................................... CYCLIC AMP AND BACTERIOPHAGE A ...................................... CYCLIC GMP ................................................................ CONCLUSION ................................................................ LITERATURE CITED ........................................................","PeriodicalId":55406,"journal":{"name":"Bacteriological Reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1976-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC413971/pdf/bactrev00053-0009.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11401899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Extrachromosomal elements as possible agents of adaptation and development. 染色体外因子作为适应和发育的可能媒介。
Pub Date : 1976-09-01 DOI: 10.1128/MMBR.40.3.552-590.1976
D. Reanney
INTRODUCTION............................................................. 552 MOLECULAR MECHANISMS OF EVOLUTION ....... ........................ 553 INSUFFICIENCY OF THE CLASSICAL MECHANISM(S) ...... ................ 553 Two Types of Molecular Evolution ............................................ 553 Role of Mutation ............................................................ 554 MUTATION: A REEXAMINATION ........... ................................. 555 STREPTOMYCIN RESISTANCE: A COMPARISON OF TWO ADAPTIVE MODES 556 TERMINOLOGY OF ECEs ................ .................................... 557 ECOLOGY OF ECEs......................................................... 558 HOST RANGES OF ECEs IN NATURAL ECOSYSTEMS ...... ................. 560 GENES CARRIED BY ECEs .............. .................................... 561 GENETIC "COMPLEXITY" OF A PROKARYOTIC SPECIES ...... ............ 563 GENETIC PROCESSES MEDIATED BY ECEs ....... ......................... 567 Dissemination of Existing Genes ........... .................................. 567 cell-to-ECE-to-cell gene transfer ............................................ 567 phage conversion........................................................... 567 ECE-to-cell-to-ECE gene transfer .......... ................................ 568 Genome Sizing ............................................................... 568 Controlled Randomization of Genomes ........................................ 568 IS elements and phage Mu ............. .................................... 568 permuted phage genomes ................................................... 569 Natural Genetic Engineering ............. .................................... 569 processes of polynucleotide exchange involving resident homology ..... ....... 569 polynucleotide exchange involving nonresident homology ...... .............. 571 evolution of R factors in bacteria .......... .............. ..................... 572 significance of sequence duplication in natural genetic engineering ..... ...... 572 universality and frequency of natural genetic engineering ...... .............. 574 Miscellaneous......................................... ..................... 575 OTHER EVIDENCE FOR POSSIBLE PROCESSES OF ECE-MEDIATED POLYNUCLEOTIDE EXCHANGE ........... ................................. 575 Dispersed State of Specific (Plant) Proteins ........ ........................... 575 "Simultaneous" Appearance of Similar Genes in Unrelated Organisms ..... ..... 575 PROCESSES OF POLYNUCLEOTIDE EXCHANGE AMONG EUKARYOTES ... 576 POSSIBLE INVOLVEMENT OF ECEs (RNA TUMOR VIRUSES) IN EMBRYOGENESIS ............................................................... 576 RNA TUMOR VIRUSES IN INTERSPECIFIC GENE TRANSFER ..... ......... 577 RNA TUMOR VIRUSES AND REGULATORY PROCESSES IN HIGHER ORGANISMS ................................................................. 578 EPIGENETIC ELEMENTS IN ANIMALS AND IN PLANTS ...... .............. 578 POSSIBLE CANDIDATES FOR EPIGEN
介绍 .............................................................552年进化的分子机制 ....... ........................553年经典机制的不足(S ) ...... ................553两种类型的分子进化 ............................................553突变的作用 ............................................................554突变:重新审视 ........... .................................555链霉素抗性:比较两种自适应模式556 ec的术语 ................ ....................................557年欧共体生态 .........................................................558主机范围ec的自然生态系统 ...... .................560个基因由欧共体 .............. ....................................561原核生物物种的遗传“复杂性”...... ............563年由ec遗传过程 ....... .........................567现有基因的传播 ........... ..................................567年cell-to-ECE-to-cell基因转移 ............................................567噬菌体转换 ...........................................................567年ECE-to-cell-to-ECE基因转移 .......... ................................568基因组大小 ...............................................................568控制的随机化的基因组 ........................................568年是元素和噬菌体μ ............. ....................................568交换噬菌体基因组 ...................................................569年自然基因工程 ............. ....................................涉及常驻同源性的多核苷酸交换过程..... .......569多核苷酸交换涉及非居民同源...... ..............571 R的进化因素细菌 .......... .............. .....................572序列重复在自然基因工程中的意义..... ......572自然基因工程的普遍性和频率...... ..............574年杂项 ......................................... .....................575其他证据的可能过程ECE-MEDIATED多核苷酸交换 ........... .................................575分散的具体状态(植物)的蛋白质 ........ ...........................575相似基因在不相关生物中的“同时”出现..... .....真核生物间多核苷酸交换的575个过程…576种可能的参与电子商务(RNA肿瘤病毒)在胚胎发生 ...............................................................576 RNA肿瘤病毒的种间基因转移..... .........577年肿瘤病毒RNA和监管流程在高等生物 .................................................................578动物和植物中的表观遗传因素...... ..............578种植物表观遗传因子的可能候选物..... ......579类病毒 ......................................................................579控制元素 .............................................................579年几何植物病毒 .......... .........................................579年一个集成的进化论 ................................580年文献引用 ......................................582
{"title":"Extrachromosomal elements as possible agents of adaptation and development.","authors":"D. Reanney","doi":"10.1128/MMBR.40.3.552-590.1976","DOIUrl":"https://doi.org/10.1128/MMBR.40.3.552-590.1976","url":null,"abstract":"INTRODUCTION............................................................. 552 MOLECULAR MECHANISMS OF EVOLUTION ....... ........................ 553 INSUFFICIENCY OF THE CLASSICAL MECHANISM(S) ...... ................ 553 Two Types of Molecular Evolution ............................................ 553 Role of Mutation ............................................................ 554 MUTATION: A REEXAMINATION ........... ................................. 555 STREPTOMYCIN RESISTANCE: A COMPARISON OF TWO ADAPTIVE MODES 556 TERMINOLOGY OF ECEs ................ .................................... 557 ECOLOGY OF ECEs......................................................... 558 HOST RANGES OF ECEs IN NATURAL ECOSYSTEMS ...... ................. 560 GENES CARRIED BY ECEs .............. .................................... 561 GENETIC \"COMPLEXITY\" OF A PROKARYOTIC SPECIES ...... ............ 563 GENETIC PROCESSES MEDIATED BY ECEs ....... ......................... 567 Dissemination of Existing Genes ........... .................................. 567 cell-to-ECE-to-cell gene transfer ............................................ 567 phage conversion........................................................... 567 ECE-to-cell-to-ECE gene transfer .......... ................................ 568 Genome Sizing ............................................................... 568 Controlled Randomization of Genomes ........................................ 568 IS elements and phage Mu ............. .................................... 568 permuted phage genomes ................................................... 569 Natural Genetic Engineering ............. .................................... 569 processes of polynucleotide exchange involving resident homology ..... ....... 569 polynucleotide exchange involving nonresident homology ...... .............. 571 evolution of R factors in bacteria .......... .............. ..................... 572 significance of sequence duplication in natural genetic engineering ..... ...... 572 universality and frequency of natural genetic engineering ...... .............. 574 Miscellaneous......................................... ..................... 575 OTHER EVIDENCE FOR POSSIBLE PROCESSES OF ECE-MEDIATED POLYNUCLEOTIDE EXCHANGE ........... ................................. 575 Dispersed State of Specific (Plant) Proteins ........ ........................... 575 \"Simultaneous\" Appearance of Similar Genes in Unrelated Organisms ..... ..... 575 PROCESSES OF POLYNUCLEOTIDE EXCHANGE AMONG EUKARYOTES ... 576 POSSIBLE INVOLVEMENT OF ECEs (RNA TUMOR VIRUSES) IN EMBRYOGENESIS ............................................................... 576 RNA TUMOR VIRUSES IN INTERSPECIFIC GENE TRANSFER ..... ......... 577 RNA TUMOR VIRUSES AND REGULATORY PROCESSES IN HIGHER ORGANISMS ................................................................. 578 EPIGENETIC ELEMENTS IN ANIMALS AND IN PLANTS ...... .............. 578 POSSIBLE CANDIDATES FOR EPIGEN","PeriodicalId":55406,"journal":{"name":"Bacteriological Reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1976-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63728712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 137
Diagnosis of plaque: an analysis of the Yersin-Kitasato controversy. 斑块的诊断:对Yersin-Kitasato争议的分析。
Pub Date : 1976-09-01 DOI: 10.1128/br.40.3.633-651.1976
D J Bibel, T H Chen
INTRODUCTION .......................................... 633 THE INVESTIGATORS ............. ............................ 634 Shibasaburo Kitasato ............ ............................. 634 Alexandre Yersin ........... ............................... 634 THE DISCOVERY OF THE PLAGUE BACILLUS .............. ................ 635 The Arrival of Yersin and Kitasato at Hong-Kong ............. ................ 635 Yersin's Report .......................................... 636 Kitasato's Reports ........... .............................. 636 A Comparison of Papers ............... .......................... 638 OPPOSITION .......................................... 638 CONFIRMATION ........... ................................ 639 THE PROBLEM .......................................... 640 AN ANALYSIS OF THE BACTERIOLOGICAL DATA .......... ................ 642 The Question of Streptococcus pneumoniae ................................... 642 Bacteriology of Plague .............. ........................... 643 CONTAMINATION ........... ............................... 646 KITASATO'S REEVALUATION ......................................... 647 CLINICAL APPLICATIONS .................. ....................... 648 CONCLUSIONS .......................................... 648 LITERATURE CITED ............ ............................. 648
{"title":"Diagnosis of plaque: an analysis of the Yersin-Kitasato controversy.","authors":"D J Bibel, T H Chen","doi":"10.1128/br.40.3.633-651.1976","DOIUrl":"https://doi.org/10.1128/br.40.3.633-651.1976","url":null,"abstract":"INTRODUCTION .......................................... 633 THE INVESTIGATORS ............. ............................ 634 Shibasaburo Kitasato ............ ............................. 634 Alexandre Yersin ........... ............................... 634 THE DISCOVERY OF THE PLAGUE BACILLUS .............. ................ 635 The Arrival of Yersin and Kitasato at Hong-Kong ............. ................ 635 Yersin's Report .......................................... 636 Kitasato's Reports ........... .............................. 636 A Comparison of Papers ............... .......................... 638 OPPOSITION .......................................... 638 CONFIRMATION ........... ................................ 639 THE PROBLEM .......................................... 640 AN ANALYSIS OF THE BACTERIOLOGICAL DATA .......... ................ 642 The Question of Streptococcus pneumoniae ................................... 642 Bacteriology of Plague .............. ........................... 643 CONTAMINATION ........... ............................... 646 KITASATO'S REEVALUATION ......................................... 647 CLINICAL APPLICATIONS .................. ....................... 648 CONCLUSIONS .......................................... 648 LITERATURE CITED ............ ............................. 648","PeriodicalId":55406,"journal":{"name":"Bacteriological Reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1976-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC413974/pdf/bactrev00053-0115.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11234351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
Microorganisms and cyanide. 微生物和氰化物。
Pub Date : 1976-09-01 DOI: 10.1128/MMBR.40.3.652-680.1976
C. Knowles
The susceptibility of cytochrome oxidases to cyanide means that cyanide is toxic to living cells and cyanide pollution causes great damage to microbial and other ecosystems. Cyanide pollution comes from both industrial wastes and a number of plants, many of agricultural importance, which are cyanogenic and release cyanide into the soil. Despite some understanding of the pathway of cyanide assimilation by aerobic microorganisms, there is little known about cyanide assimilation by anaerobic microorganisms. The author discusses cyanide production, utilization, degradation, and resistance by microorganisms. He concludes that among the most primitive organisms were some that could metabolize cyanide, perhaps in conjunction with other carbon and nitrogen sources. 199 references, 4 figures, 2 tables.
细胞色素氧化酶对氰化物的敏感性意味着氰化物对活细胞具有毒性,氰化物污染对微生物和其他生态系统造成极大的破坏。氰化物污染来自工业废物和许多植物,其中许多对农业很重要,它们会产生氰化物并将氰化物释放到土壤中。尽管对好氧微生物的氰化物同化途径有一定的了解,但对厌氧微生物的氰化物同化途径知之甚少。作者讨论了微生物对氰化物的生产、利用、降解和抗性。他的结论是,在最原始的生物中,有一些可能与其他碳和氮源一起代谢氰化物。199篇参考文献,4张图,2张表。
{"title":"Microorganisms and cyanide.","authors":"C. Knowles","doi":"10.1128/MMBR.40.3.652-680.1976","DOIUrl":"https://doi.org/10.1128/MMBR.40.3.652-680.1976","url":null,"abstract":"The susceptibility of cytochrome oxidases to cyanide means that cyanide is toxic to living cells and cyanide pollution causes great damage to microbial and other ecosystems. Cyanide pollution comes from both industrial wastes and a number of plants, many of agricultural importance, which are cyanogenic and release cyanide into the soil. Despite some understanding of the pathway of cyanide assimilation by aerobic microorganisms, there is little known about cyanide assimilation by anaerobic microorganisms. The author discusses cyanide production, utilization, degradation, and resistance by microorganisms. He concludes that among the most primitive organisms were some that could metabolize cyanide, perhaps in conjunction with other carbon and nitrogen sources. 199 references, 4 figures, 2 tables.","PeriodicalId":55406,"journal":{"name":"Bacteriological Reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1976-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63728655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 307
The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. 作为脂肪酸合成抑制剂的一种新的生物化学工具,抗生素蓝绿蛋白。
Pub Date : 1976-09-01 DOI: 10.1128/MMBR.40.3.681-697.1976
S. Ōmura
One ofthe most versatile uses of antibiotics is as potent drugs for clinical application. In recent years, attention has also been paid to agricultural uses of antibiotics, such as for feed additives for protecting plants and livestock against infectious diseases and for accelerating their growth. They are also used as food additives to retain freshness for an extended period. The usefulness of antibiotics is not limited only to our daily needs, but also encompasses our research interests: they offer us remarkable experimental devices for biochemistry novel biochemical tools, which have made a significant contribution to progress in this field (18). Cerulenin, an antibiotic discovered by Hata et al. in 1960, was originally found as an antifungal antibiotic (30). Studies of its mode of action have revealed that it specifically inhibits the biosynthesis of fatty acids and sterols involving yeasts (55, 56). It should be particularly noted that such specificity of cerulenin has been used by investigators in various fields of biochemistry. In this connection, the present review deals with studies, which have hitherto been reported, on the production, isolation, structure, and mode of action of cerulenin and its application as a biochemical tool. Unfortunately, the instability of the antibiotic in the animal body prevents its use in therapy as an antimicrobial agent or as an antilipogenic agent.
抗生素最广泛的用途之一是作为临床应用的强效药物。近年来,人们也注意到抗生素的农业用途,例如作为饲料添加剂,保护植物和牲畜免受传染病的侵害,并加速它们的生长。它们也被用作食品添加剂,以保持较长时间的新鲜度。抗生素的用途不仅限于我们的日常需要,而且还包括我们的研究兴趣:它们为我们提供了出色的生物化学实验设备,新颖的生物化学工具,为这一领域的进步做出了重大贡献(18)。Cerulenin是Hata等人于1960年发现的一种抗生素,最初被发现是作为抗真菌抗生素(30)。对其作用方式的研究表明,它特异性地抑制脂肪酸和甾醇的生物合成涉及酵母(55,56)。应该特别指出的是,蓝蓝蛋白的这种特异性已被研究人员用于生物化学的各个领域。在这方面,本文综述了迄今为止已报道的关于蓝蓝蛋白的生产、分离、结构和作用方式及其作为生化工具的应用的研究。不幸的是,抗生素在动物体内的不稳定性阻碍了它在治疗中作为抗微生物剂或抗脂剂的使用。
{"title":"The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis.","authors":"S. Ōmura","doi":"10.1128/MMBR.40.3.681-697.1976","DOIUrl":"https://doi.org/10.1128/MMBR.40.3.681-697.1976","url":null,"abstract":"One ofthe most versatile uses of antibiotics is as potent drugs for clinical application. In recent years, attention has also been paid to agricultural uses of antibiotics, such as for feed additives for protecting plants and livestock against infectious diseases and for accelerating their growth. They are also used as food additives to retain freshness for an extended period. The usefulness of antibiotics is not limited only to our daily needs, but also encompasses our research interests: they offer us remarkable experimental devices for biochemistry novel biochemical tools, which have made a significant contribution to progress in this field (18). Cerulenin, an antibiotic discovered by Hata et al. in 1960, was originally found as an antifungal antibiotic (30). Studies of its mode of action have revealed that it specifically inhibits the biosynthesis of fatty acids and sterols involving yeasts (55, 56). It should be particularly noted that such specificity of cerulenin has been used by investigators in various fields of biochemistry. In this connection, the present review deals with studies, which have hitherto been reported, on the production, isolation, structure, and mode of action of cerulenin and its application as a biochemical tool. Unfortunately, the instability of the antibiotic in the animal body prevents its use in therapy as an antimicrobial agent or as an antilipogenic agent.","PeriodicalId":55406,"journal":{"name":"Bacteriological Reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1976-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63728862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 360
Enterobacterial common antigen. 肠杆菌共同抗原。
Pub Date : 1976-09-01 DOI: 10.1128/br.40.3.591-632.1976
P H Mäkelä, H Mayer
INTRODUCTION .............. ................................ 591 DISCOVERY AND DEFINITIONS ............................................. 591 SEROLOGICAL METHODS ............................................. 592 Hemagglutination (HA), Hemolysis, and Hemagglutination Inhibition (HAI) ... 592 Other Serological Methods ............................................. 593 CHEMISTRY .............................................. 594 Studies on Immunogenic Strains ............................................. 594 Studies on Nonimmunogenic Strains ......................................... 595 Chemical Identity of ECA ............................................. 600 GENETIC DETERMINATION OF ECA ......................................... 602 The rMe Genes .............................................. 602 Role of the rib Region ..................... ........................ 604 Mutants of a New, "rif," Type ............................................. 605 Genetics of ECA in Immunogenic Strains .................. .................. 606 Conclusions .............................................. 606 IMMUNOGENICITY ................. ............................. 607 Immunogenic Strains ............................................ 607 Interference by LPS ............... ............................. 610 Importance of the Form of Aggregation ...................................... 611 Immunological Tolerance? ............................................ 613 ECA IN THE BACTERIAL CELL ............................................ 614 CLINICAL IMPLICATIONS ............................................ 614 Immediate Biological Effects of ECA ........................................ 614 Is ECA a Virulence Factor? ............................................ 615 Prevalence of Antibodies to ECA ............................................ 615 ECA and anti-ECA Antibodies in Relation to Disease .......... ................ 616 Anti-ECA in Experimental Infection ......................................... 619 Antigenic Similarities Between ECA and Animal Tissues ........ .............. 620 OTHER CROSS-REACTIVITIES AND RELATED ANTIGENS ...... ............ 620 Various "Common" Antigens ................................................ 620 ManNUA-Containing Bacterial Antigens ................ ..................... 622 DISTRIBUTION OF ECA: TAXONOMIC IMPLICATIONS ....... ............... 622 SUMMARY ............ ..................................... 623 LITERATURE CITED ................ a 624
{"title":"Enterobacterial common antigen.","authors":"P H Mäkelä, H Mayer","doi":"10.1128/br.40.3.591-632.1976","DOIUrl":"https://doi.org/10.1128/br.40.3.591-632.1976","url":null,"abstract":"INTRODUCTION .............. ................................ 591 DISCOVERY AND DEFINITIONS ............................................. 591 SEROLOGICAL METHODS ............................................. 592 Hemagglutination (HA), Hemolysis, and Hemagglutination Inhibition (HAI) ... 592 Other Serological Methods ............................................. 593 CHEMISTRY .............................................. 594 Studies on Immunogenic Strains ............................................. 594 Studies on Nonimmunogenic Strains ......................................... 595 Chemical Identity of ECA ............................................. 600 GENETIC DETERMINATION OF ECA ......................................... 602 The rMe Genes .............................................. 602 Role of the rib Region ..................... ........................ 604 Mutants of a New, \"rif,\" Type ............................................. 605 Genetics of ECA in Immunogenic Strains .................. .................. 606 Conclusions .............................................. 606 IMMUNOGENICITY ................. ............................. 607 Immunogenic Strains ............................................ 607 Interference by LPS ............... ............................. 610 Importance of the Form of Aggregation ...................................... 611 Immunological Tolerance? ............................................ 613 ECA IN THE BACTERIAL CELL ............................................ 614 CLINICAL IMPLICATIONS ............................................ 614 Immediate Biological Effects of ECA ........................................ 614 Is ECA a Virulence Factor? ............................................ 615 Prevalence of Antibodies to ECA ............................................ 615 ECA and anti-ECA Antibodies in Relation to Disease .......... ................ 616 Anti-ECA in Experimental Infection ......................................... 619 Antigenic Similarities Between ECA and Animal Tissues ........ .............. 620 OTHER CROSS-REACTIVITIES AND RELATED ANTIGENS ...... ............ 620 Various \"Common\" Antigens ................................................ 620 ManNUA-Containing Bacterial Antigens ................ ..................... 622 DISTRIBUTION OF ECA: TAXONOMIC IMPLICATIONS ....... ............... 622 SUMMARY ............ ..................................... 623 LITERATURE CITED ................ a 624","PeriodicalId":55406,"journal":{"name":"Bacteriological Reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1976-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC413973/pdf/bactrev00053-0073.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11284109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Sulfate ester formation and hydrolysis: a potentially important yet often ignored aspect of the sulfur cycle of aerobic soils. 硫酸盐酯的形成和水解:一个潜在的重要但经常被忽视的方面的好氧土壤的硫循环。
Pub Date : 1976-09-01 DOI: 10.1128/br.40.3.698-721.1976
J W Fitzgerald
INTRODUCTION.............................................................. 698 STATUS OF SULFUR IN AEROBIC SOILS..................................... 698 Inorganic Sulfur ........................................................... 698 Carbon-Bonded Sulfur ....................................................... 699 Ester Sulfate ............................................................... 700 ORIGINS OF SOIL ESTER SULFATE ......... ............................... 702 Mammalian Sources ......................................................... 702 Microbial and Plant Sources .................................................. 702 Generation of Choline Sulfate ..................... ........................... 703 MINERALIZATION OF ESTER SULFATE .......... .......................... 704 PHYSIOLOGICAL FUNCTION OF MICROBIAL SULFOHYDROLASES ....... 705 Regulation of Sulfohydrolase Synthesis and Activity ........ ................... 705 Localization of Sulfohydrolase Activity ............ ........................... 707 Sulfohydrolase Stability In Vivo and In Vitro ......... ........................ 709 SOURCES OF INORGANIC SULFATE FOR AEROBIC SOILS ...... .......... 709 Elemental and Sulfide Sulfur ................................................. 709 Sulfate Ester Hydrolysis ..................................................... 710 Atmospheric Pollution ....................................................... 710 Sulfonates, Sulfamates, and the Sulfated-Thioglycosides ....... ................ 710 S-Containing Amino Acids................................................... 711 PRACTICAL AND FUTURE CONSIDERATIONS ........ ...................... 711 LITERATURE CITED......................................................... 713
{"title":"Sulfate ester formation and hydrolysis: a potentially important yet often ignored aspect of the sulfur cycle of aerobic soils.","authors":"J W Fitzgerald","doi":"10.1128/br.40.3.698-721.1976","DOIUrl":"https://doi.org/10.1128/br.40.3.698-721.1976","url":null,"abstract":"INTRODUCTION.............................................................. 698 STATUS OF SULFUR IN AEROBIC SOILS..................................... 698 Inorganic Sulfur ........................................................... 698 Carbon-Bonded Sulfur ....................................................... 699 Ester Sulfate ............................................................... 700 ORIGINS OF SOIL ESTER SULFATE ......... ............................... 702 Mammalian Sources ......................................................... 702 Microbial and Plant Sources .................................................. 702 Generation of Choline Sulfate ..................... ........................... 703 MINERALIZATION OF ESTER SULFATE .......... .......................... 704 PHYSIOLOGICAL FUNCTION OF MICROBIAL SULFOHYDROLASES ....... 705 Regulation of Sulfohydrolase Synthesis and Activity ........ ................... 705 Localization of Sulfohydrolase Activity ............ ........................... 707 Sulfohydrolase Stability In Vivo and In Vitro ......... ........................ 709 SOURCES OF INORGANIC SULFATE FOR AEROBIC SOILS ...... .......... 709 Elemental and Sulfide Sulfur ................................................. 709 Sulfate Ester Hydrolysis ..................................................... 710 Atmospheric Pollution ....................................................... 710 Sulfonates, Sulfamates, and the Sulfated-Thioglycosides ....... ................ 710 S-Containing Amino Acids................................................... 711 PRACTICAL AND FUTURE CONSIDERATIONS ........ ...................... 711 LITERATURE CITED......................................................... 713","PeriodicalId":55406,"journal":{"name":"Bacteriological Reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1976-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC413977/pdf/bactrev00053-0180.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11981129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Group B streptococci in human disease. B群链球菌在人类疾病中的作用。
Pub Date : 1976-09-01 DOI: 10.1128/br.40.3.774-792.1976
M J Patterson, A El Batool Hafeez
INTRODUCTION .............................. 774 History and Nomenclature .............................. 774 Human Disease .............................. 774 THE AGENT .............................. 775 Strains of Bovine and Human Origin ............ .................. 775 Seroclassification .............................. 775 Virulence Factors .............................. 776 Metabolism .............................. 777 CLINICAL DISEASE SPECTRUM ......... ..................... 777 Early Recognition ............................. 777 Neonatal Disease .............................. 778 Disease in Older Children and Adults .......... ................... 779 PATHOGENESIS .............................. 779 Perinatal Colonization .............................. 779 Postnatal Colonization ............................. 780 LABORATORY DIAGNOSIS ............................. 780 Selective Broth Medium for Primary Isolation ................................. 780 Presumptive Identification ............ ......................... 781 Serological Identification .......... ........................... 782 IMMUNOLOGY ...................................... 782 Host Antibody Response .......... ........................... 782 Leukocytic Response ........ ............................. 783 EPIDEMIOLOGY ...................................... 783 Incidence ...................................... 783 Source ...................................... 784 Transmission ...................................... 784 Microbial Persistence ......... ............................ 784 Race ...................................... 785 Sex ..................................... 785 Other Factors ...................................... 785 PROPHYLAXIS AND TREATMENT ...................................... 785 Spectrum of Antimicrobial Susceptibility ..................................... 785 Carrier Prophylaxis ..................................... 785 CONCLUDING REMARKS .......... ........................... 787 LITERATURE CITED ........ ............................. 787
{"title":"Group B streptococci in human disease.","authors":"M J Patterson, A El Batool Hafeez","doi":"10.1128/br.40.3.774-792.1976","DOIUrl":"https://doi.org/10.1128/br.40.3.774-792.1976","url":null,"abstract":"INTRODUCTION .............................. 774 History and Nomenclature .............................. 774 Human Disease .............................. 774 THE AGENT .............................. 775 Strains of Bovine and Human Origin ............ .................. 775 Seroclassification .............................. 775 Virulence Factors .............................. 776 Metabolism .............................. 777 CLINICAL DISEASE SPECTRUM ......... ..................... 777 Early Recognition ............................. 777 Neonatal Disease .............................. 778 Disease in Older Children and Adults .......... ................... 779 PATHOGENESIS .............................. 779 Perinatal Colonization .............................. 779 Postnatal Colonization ............................. 780 LABORATORY DIAGNOSIS ............................. 780 Selective Broth Medium for Primary Isolation ................................. 780 Presumptive Identification ............ ......................... 781 Serological Identification .......... ........................... 782 IMMUNOLOGY ...................................... 782 Host Antibody Response .......... ........................... 782 Leukocytic Response ........ ............................. 783 EPIDEMIOLOGY ...................................... 783 Incidence ...................................... 783 Source ...................................... 784 Transmission ...................................... 784 Microbial Persistence ......... ............................ 784 Race ...................................... 785 Sex ..................................... 785 Other Factors ...................................... 785 PROPHYLAXIS AND TREATMENT ...................................... 785 Spectrum of Antimicrobial Susceptibility ..................................... 785 Carrier Prophylaxis ..................................... 785 CONCLUDING REMARKS .......... ........................... 787 LITERATURE CITED ........ ............................. 787","PeriodicalId":55406,"journal":{"name":"Bacteriological Reviews","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1976-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC413980/pdf/bactrev00053-0256.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11981133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Bacteriological Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1